Selecta Biosciences Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
52
- Latest Deal Type
-
M&A
Selecta Biosciences General Information
Description
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Contact Information
Website
www.selectabio.com(Operating Subsidiary)
Corporate Office
- 65 Grove Street
- Watertown, MA 02472
- United States
Corporate Office
- 65 Grove Street
- Watertown, MA 02472
- United States
Selecta Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Merger/Acquisition | 13-Nov-2023 | Completed | Generating Revenue | |||
| 18. PIPE | 28-Jul-2020 | Completed | Generating Revenue | |||
| 17. PIPE | 19-Dec-2019 | Completed | Generating Revenue | |||
| 16. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 15. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 14. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 13. Debt - General | 14-Sep-2017 | Completed | Generating Revenue | |||
| 12. PIPE | 27-Jun-2017 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Open Market | 21-Apr-2017 | $218M | Completed | Generating Revenue | ||
| 10. IPO | 22-Jun-2016 | $70M | $218M | Completed | Generating Revenue |
Selecta Biosciences Comparisons
Industry
Financing
Details
Selecta Biosciences Competitors (42)
One of Selecta Biosciences’s 42 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Ambrx | Formerly PE-Backed | San Diego, CA | ||||
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ |
Selecta Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Selecta Biosciences Patents
Selecta Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-1023205-A | Support for the rest of a seated traveler | Inactive | 10-Aug-1950 |
Selecta Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Selecta Biosciences Former Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AJU IB Investment | Venture Capital | Minority | ||
| Amzak Capital Management | Family Office | Minority | ||
| Amzak Health | Venture Capital | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Boxer Capital | Corporate Venture Capital | Minority |
Selecta Biosciences Investments & Acquisitions (2)
Selecta Biosciences’s most recent deal was a Reverse Merger with Cartesian Therapeutics for . The deal was made on 13-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cartesian Therapeutics | 13-Nov-2023 | Reverse Merger | Drug Discovery | ||
| Cyrus Biotechnology | 05-Oct-2021 | Later Stage VC | Drug Discovery |
Selecta Biosciences FAQs
-
When was Selecta Biosciences founded?
Selecta Biosciences was founded in 2008.
-
Where is Selecta Biosciences headquartered?
Selecta Biosciences is headquartered in Watertown, MA.
-
What is the size of Selecta Biosciences?
Selecta Biosciences has 52 total employees.
-
What industry is Selecta Biosciences in?
Selecta Biosciences’s primary industry is Drug Discovery.
-
Is Selecta Biosciences a private or public company?
Selecta Biosciences is a Private company.
-
What is Selecta Biosciences’s current revenue?
The current revenue for Selecta Biosciences is .
-
How much funding has Selecta Biosciences raised over time?
Selecta Biosciences has raised $398M.
-
Who are Selecta Biosciences’s investors?
AJU IB Investment, Amzak Capital Management, Amzak Health, BVF Partners, and Boxer Capital are 5 of 26 investors who have invested in Selecta Biosciences.
-
Who are Selecta Biosciences’s competitors?
CytomX Therapeutics, Ambrx, Editas Medicine, Cristal Therapeutics, and Lisata Therapeutics are some of the 42 competitors of Selecta Biosciences.
-
When was Selecta Biosciences acquired?
Selecta Biosciences was acquired on 13-Nov-2023.
-
Who acquired Selecta Biosciences?
Selecta Biosciences was acquired by Cartesian Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
